Skip to main content

gabapentin

Generic: GABAPENTIN·Brand: GABAPENTIN, GRALISE, Gabarone, Gralise, Horizant, NEURONTIN, Neurontin, RELGAABI, Relgaabi

gabapentin: 6 clinical trials tracked.

gabapentin evidence translation

What we can confirm

6 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about gabapentin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence4 indications · 1 study sponsors
Clinical Trial Registry Records (6)

A Phase 4, Randomized, Double-Blind, Placebo and Active-Controlled, Single-Dose, Six-Way Crossover Study Evaluating the Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug- Dependent, Recreational Opioid Users

NCT07813026Registry updated 2026-09-10·Phase 4·VTRS
Recruiting

Primary endpoint: Bipolar Visual Analog Scale (VAS) for "Drug Liking" Maximum Effect (Emax)

InterventionalRandomizeddouble60 targetStarted 2026-08Completion 2027-021 site · United StatesViatris Inc.

High-Dose Prophylactic Gabapentin (HOPE) to Prevent Opioid Use for Oral Mucositis Pain During Head and Neck Chemoradiotherapy: A Phase III Clinical Trial

NCT06992427Registry updated 2026-10-02·Phase 3
Recruiting

Primary endpoint: Need to use opioids during chemoradiation therapy (CRT)

InterventionalRandomizedtriple228 targetStarted 2025-06Completion 2031-0450 sites · United StatesAlliance for Clinical Trials in Oncology

A Phase IV, Longitudinal, Observational Study Examining Real-World Outcomes of Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vasomotor Symptoms

NCT06049797Registry updated 2026-06-05
Completed

Primary endpoint: Mean change from baseline to week 12 in symptom bother measured by the Menopause-Specific Quality of Life Domain (MENQoL) 1-week recall VMS domain score

Observational999 enrolledStarted 2023-11Completion 2026-0548 sites · United StatesAstellas Pharma Global Development, Inc.

Feasibility of Early Gabapentin as an Intervention for Neurorecovery

NCT05302999Registry updated 2026-10-01·Phase 4
Completed

Primary endpoint: Number of participants recruited

InterventionalRandomizeddouble26 enrolledStarted 2022-03Completion 2026-031 site · United StatesMetroHealth Medical Center

Biomarker-Driven Pharmacological Treatment for Autism Spectrum Disorder

NCT05063656Registry updated 2026-02-20·Phase 4
Completed

Primary endpoint: Right Anterior Insula GABA level

Interventionalopen16 enrolledStarted 2022-02Completion 2025-121 site · United StatesDavid Cochran

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

NCT03511118Registry updated 2026-02-11·N/A
Recruiting

Primary endpoint: M/P ratio

Observational1,600 targetStarted 2018-10Completion 2027-0722 sites · Canada, United StatesDuke University